Thibaut F, Cordier B, Kuhn J M
Department of Psychiatry, Psychiatric Hospital, Sotteville les Rouen, France.
Acta Psychiatr Scand. 1993 Jun;87(6):445-50. doi: 10.1111/j.1600-0447.1993.tb03402.x.
Six men with severe paraphilia had been treated with depot gonadotrophin luteinizing releasing hormone analogue (GnRHa) (triptorelin 3.75 mg per month intramuscularly). In 5 cases, the treatment ended their deviant sexual behavior and markedly decreased their sexual fantasies and activities without further significant side effects than those related to hypoandrogenism. This clinical improvement was parallel to the gradual decrease of plasma testosterone level to castration values within the first month. The beneficial effect of this treatment had been maintained at follow-up varying from 7 months to 3 years. One patient interrupted the treatment at the end of the first year and relapsed within 10 weeks. GnRHa treatment, which leads to reversible castration, may constitute a promising treatment of paraphilic behavior and may favor the possibility of concurrent psychotherapy.
六名患有严重性偏好障碍的男性接受了长效促性腺激素释放激素类似物(GnRHa)(曲普瑞林,每月3.75毫克,肌肉注射)治疗。5例患者的治疗结束了他们的异常性行为,并显著减少了他们的性幻想和性活动,除了与雄激素缺乏相关的副作用外,没有进一步的明显副作用。这种临床改善与血浆睾酮水平在第一个月内逐渐降至去势值平行。这种治疗的有益效果在7个月至3年的随访中得以维持。一名患者在第一年末中断治疗,并在10周内复发。GnRHa治疗可导致可逆性去势,可能是一种有前景的性偏好行为治疗方法,并且可能有利于同时进行心理治疗。